Navigation Links
Reportlinker Adds Europe Drug Delivery Devices Market Outlook to 2017
Date:6/8/2011

NEW YORK, June 8, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Europe Drug Delivery Devices Market Outlook to 2017

http://www.reportlinker.com/p0336549/Europe-Drug-Delivery-Devices-Market-Outlook-to-2017.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=NoCategory

Europe Drug Delivery Devices Market Outlook to 2017

Summary

GlobalData's new report, "Europe Drug Delivery Devices Market Outlook to 2017" provides key market data on the Europe Drug Delivery Devices market – France, Germany, Italy, Spain and United Kingdom. The report provides value (USD million) data for all the market categories – Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Needle Free Injections. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Countries covered include France, Germany, Italy, Spain and United Kingdom.

- Market size and company share data for Drug Delivery Devices market categories – Central Venous Catheters, Infusion Systems,Metered Dose Inhaler Devices and Needle Free Injections.

- Annualized market revenues (USD million) data for each of the market categories in each of the co
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Reportlinker Adds Asia-Pacific Drug Delivery Devices Market Outlook to 2017
2. Reportlinker Adds Hearing Aid Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2017
3. Reportlinker Adds Renal Dialysis Equipment - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
4. Reportlinker Adds Cardiovascular Monitoring and Diagnostic Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
5. Reportlinker Adds Cancer Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2017
6. Reportlinker Adds Myelodysplastic Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2017
7. Reportlinker Adds Interventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
8. Reportlinker Adds Chinas Guidebook for Pharmaceutical Patent Protection
9. Reportlinker Adds Greece Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2017
10. Reportlinker Adds Global Top 10 Pharmaceutical Companies: Industry, Financial and SWOT Analysis
11. Reportlinker Adds the Future of In Vitro and In Vivo Diagnostic Integration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... YORK, Pa. , July 29, 2015  Unilife ... and ASX: UNS), a developer, manufacturer and supplier of ... a multifaceted financing strategy that provides the Company with ... Unilife has signed an equity purchase ... Capital Fund, LLC ("LPC"), a Chicago ...
(Date:7/29/2015)... 2015  According to data released today by the ... monthly Medicare Part D premium is expected to remain ... originally projected, the Pharmaceutical Care Management Association (PCMA) said. ... be a bright spot in American health care. By ... and using cutting edge, cost-saving tools like pharmacy networks ...
(Date:7/29/2015)... and CAMBRIDGE, Mass. , July ... ISIS ), the leader in RNA-targeted therapeutics, and ... that The New England Journal of Medicine ... clinical study evaluating volanesorsen (formerly ISIS-APOCIII Rx ) ... triglycerides. This publication follows the December 2014 publication ...
Breaking Medicine Technology:Unilife Announces Multifaceted Financing Strategy 2Unilife Announces Multifaceted Financing Strategy 3Unilife Announces Multifaceted Financing Strategy 4Unilife Announces Multifaceted Financing Strategy 5Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine 2Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine 3Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine 4Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine 5Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine 6Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine 7
... , BETHESDA, Md. , Feb. 10 ... Inc. (Nasdaq: MITI ) outlined the design of a ... acute lymphocytic leukemia (ALL), highlighted clinical data demonstrating the breadth ... to expand clinical development of blinatumomab in the U.S. , ...
... , GREENFIELD, Mass. , Feb. 10 ... can be sure meats and dairy products they buy have been ... Association (OTA) in response to a CBS Evening News with ... and 10. , "Organic practices recognize and respect the powerful ...
Cached Medicine Technology:Micromet Highlights Clinical Plans and Regulatory Strategy for Lead Product Candidate Blinatumomab at its Annual R&D Day 2Micromet Highlights Clinical Plans and Regulatory Strategy for Lead Product Candidate Blinatumomab at its Annual R&D Day 3Micromet Highlights Clinical Plans and Regulatory Strategy for Lead Product Candidate Blinatumomab at its Annual R&D Day 4Micromet Highlights Clinical Plans and Regulatory Strategy for Lead Product Candidate Blinatumomab at its Annual R&D Day 5Organic Is Answer to Those Seeking Foods Produced Without Antibiotics 2Organic Is Answer to Those Seeking Foods Produced Without Antibiotics 3